Essex Investment Management CO LLC Aptinyx Inc. Transaction History

Essex Investment Management CO LLC

  • $536 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 06, 2019
SELL
$16.15 - $28.93 $181,994 - $326,012
-11,269 Closed
0 $0
Q3 2018

Oct 16, 2018
SELL
$20.21 - $31.85 $392,902 - $619,195
-19,441 Reduced 63.31%
11,269 $326,000
Q2 2018

Jul 17, 2018
BUY
$19.83 - $24.17 $608,979 - $742,260
30,710 New
30,710 $742,000

About Aptinyx Inc.

APTX Quotes by TradingView
  • Ticker APTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,715,696
  • Description
  • Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...
More about APTX
Track This Portfolio

Track Essex Investment Management CO LLC Portfolio

Follow Essex Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email